Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    gao4915g
Show Display Options
Rank Status Study
1 Active, not recruiting
Has Results
A Study of Obinutuzumab [RO5072759 (GA101)] in Combination With CHOP Chemotherapy in Patients With Previously Untreated Advanced Diffuse Large B-Cell Lymphoma (GATHER)
Condition: Lymphoma, B-Cell
Interventions: Drug: obinutuzumab;   Drug: cyclophosphamide;   Drug: doxorubicin;   Drug: prednisone;   Drug: vincristine

Indicates status has not been verified in more than two years